A 99mtc-labeled somatostatin analog for lung cancer diagnosis and its preparation method
A technology for somatostatin and analogs, applied in the field of biomedicine, can solve the problem of not recommending lung cancer labeling, etc., and achieve the effects of intuitive and accurate labeling results, high yield, and good separation effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] Example 1 Polypeptide Synthesis and Purification and Labeling
[0030] 1. Main reagents and synthesis steps
[0031] (1) Main reagents:
[0032] Fmoc-Thr(tBu)-Rink-amide AM resin(0.3-0.6mmol / g), Fmoc-Cys(Trt)-OH, Fmoc-Thr(tbu)-OH, Fmoc-Lys(Boc)-OH, Fmoc- D-Trp(Boc)-OH, Fmoc-Tyr(tbu)-OH, Fmoc-D-Phe-OH, Boc-Hynic, HBTU, HOBt, Diisopropylethylamine (DIEA), Piperidine (PIP), Dimethylformamide (DMF), dichloromethane (DCM), methanol (MeOH), anhydrous methyl tert-butyl ether (MTBE), trifluoroacetic acid (TFA), triisopropylsilane (TIPS), ethyl Dithiol (EDT), acetonitrile (ACN), pure water (H2O), phosphate buffered saline (PBS), Kaiser reagent.
[0033] (2). HYNIC-Fpa(3)-TATE synthesis method route:
[0034] Main equipment:
[0035] Refrigerated centrifuge (Shanghai Luxiang TDZ5-WS), preparative high performance liquid chromatography (Chuangxin Tongheng LC6000), analytical high performance liquid chromatography (Thermo Fisher Ultimate 3000), mass spectrometer (Waters ZQ-200...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


